Prelude Therapeutics, Inc. (PRLD)
3.32
+0.09
(+2.79%)
USD |
NASDAQ |
Oct 15, 16:00
3.32
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Cash from Operations (TTM) : -33.26M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -33.26M |
| March 31, 2026 | -43.76M |
| December 31, 2025 | -56.30M |
| September 30, 2025 | -100.16M |
| June 30, 2025 | -108.35M |
| March 31, 2025 | -105.33M |
| December 31, 2024 | -102.89M |
| September 30, 2024 | -105.72M |
| June 30, 2024 | -104.11M |
| March 31, 2024 | -108.72M |
| Date | Value |
|---|---|
| December 31, 2023 | -107.06M |
| September 30, 2023 | -106.41M |
| June 30, 2023 | -101.17M |
| March 31, 2023 | -91.97M |
| December 31, 2022 | -83.73M |
| September 30, 2022 | -86.50M |
| June 30, 2022 | -87.84M |
| March 31, 2022 | -89.28M |
| December 31, 2021 | -83.53M |
| September 30, 2021 | -72.68M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Q32 Bio, Inc. | -19.83M |
| Intellia Therapeutics, Inc. | -346.64M |
| Twist Bioscience Corp. | -53.07M |
| Beam Therapeutics, Inc. | -359.38M |
| Revolution Medicines, Inc. | -1.223B |